C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/51 (2006.01) A61K 39/29 (2006.01) C07K 14/08 (2006.01) C07K 14/085 (2006.01) C07K 19/00 (2006.01) C12N 9/10 (2006.01) C12N 15/62 (2006.01) C12Q 1/68 (2006.01) G01N 33/576 (2006.01)
Patent
CA 2170521
The present invention relates generally to molecules such as peptides, polypeptides and proteins which carry epitopes and in particular B cell epitopes from antigenic proteins encoded by Hepatitis E Virus. These molecules are selectively immunoreactive to convalescent and/or acute phase circulating antibodies to the Hepatitis E Virus and are useful in the development of diagnostic therapeutical and prophylactic agents for Hepatitis E Virus.
L'invention a trait d'une façon générale à des molécules telles que des peptides, des polypeptides ou des protéines porteurs d'épitopes et en particulier d'épitopes de cellules B de protéines antigènes codées par le virus de l'hépatite E. Ces molécules, sélectivement immunoréactives vis à vis des anticorps du virus de l'hépatite E en phase de convalescence ou aiguë, servent à la mise au point d'agents diagnostiques, thérapeutiques et prophylactiques du virus de l'hépatite E.
Anderson David Andrew
Hui Zhuang
Li Fan
Locarnini Stephen Alistair
Torresi Joseph
Fetherstonhaugh & Co.
Macfarlane Burnet Centre For Medical Research Limited (the)
LandOfFree
Immunoreactive antigens of hepatitis e virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoreactive antigens of hepatitis e virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoreactive antigens of hepatitis e virus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1627480